Down Syndrome Regression Disorder vs a Mother’s Love: A Washington Post Mother’s Day Feature
For many families, the threat of Down Syndrome Regression Disorder (DSRD) feels harrowing and constant. Gratefully, two scientists are leading the charge to understand and treat this heartbreaking condition, and thanks to one relentless mom/advocate, they’re working together.
Crnic Institute Executive Director Dr. Joaquin Espinosa and Children’s Hospital Los Angeles Director of Neuroimmunology had no idea they had been developing complementary research on DSRD until mom Linda Roan of Boulder, CO connected the dots for them. The two scientists joined forces to create the first-ever randomized clinical control trial to treat DSRD and secure its funding through NIH’s INCLUDE initiative.
Learn more about this groundbreaking clinical trial.
Recent Posts
- Down Syndrome Regression Disorder vs a Mother’s Love: A Washington Post Mother’s Day Feature
- 2023 AcceptAbility Gala Social Media Images
- Science MINDS: Michelle Sie Whitten, President, CEO & Co-Founder of Global Down Syndrome Foundation
- New NIH-funded Study Will Investigate a Debilitating Condition Known as Down Syndrome Regression Disorder (DSRD)
- NIH-funded Project Data Hub Aims to Revolutionize Down Syndrome Research With the Crnic Institute